SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-05-039004
Filing Date
2005-08-12
Accepted
2005-08-12 14:06:16
Documents
8
Period of Report
2005-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a05-12868_110q.htm 10-Q 708972
2 EX-10.1 a05-12868_1ex10d1.htm EX-10.1 117264
3 EX-10.2 a05-12868_1ex10d2.htm EX-10.2 11814
4 EX-10.3 a05-12868_1ex10d3.htm EX-10.3 35991
5 EX-10.4 a05-12868_1ex10d4.htm EX-10.4 59518
6 EX-31.1 a05-12868_1ex31d1.htm EX-31.1 10297
7 EX-31.2 a05-12868_1ex31d2.htm EX-31.2 10349
8 EX-32 a05-12868_1ex32.htm EX-32 7914
  Complete submission text file 0001104659-05-039004.txt   963604
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30319 | Film No.: 051020658
SIC: 2834 Pharmaceutical Preparations